Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-09-23

Clinical Trial Update: Steroid Injection for the Treatment of Greater Trochanteric Pain Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating steroid injections for bursitis (greater trochanteric pain syndrome) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Emory University | Conditions: Bursitis | Phase 4 | Status: WITHDRAWN